论文部分内容阅读
通过将符合手足口病(普通型)标准病人67例随机分为两组进行追踪观察,两组性别、病情轻重无显著差异(P>0.05)。两组均予利巴韦林(10～15mg/kg.d)、喜炎平(0.2～0.4ml/kg.d)抗病毒退热对症治疗;治疗组加用康复新液口服或含服及外搽皮疹,对两组治疗效果进行比较。治疗组显效率94%,对照组69%,差异有显著性(P<0.01)。结论:康复新液治疗儿童手足口病(普通型),有利于改善症状,缩短病程,加快溃疡愈合,皮疹消退。
67 patients with standard foot and mouth disease (common type) were randomly divided into two groups and followed up. There was no significant difference between the two groups in gender and severity (P> 0.05). Both groups were treated with ribavirin (10 ~ 15mg / kg.d), Xiyanping (0.2 ~ 0.4ml / kg.d) anti-virus fever symptomatic treatment; the treatment group with Kangfuxin liquid oral or buccal Waicha rash, the treatment effect of the two groups were compared. The treatment group was 94% effective rate, 69% in the control group, the difference was significant (P <0.01). Conclusion: Kangfuxin solution for the treatment of hand, foot and mouth disease in children (common type) is beneficial to improve the symptoms, shorten the course of disease, accelerate the healing of ulcer and eliminate the rash.